Pascal and Francis Bibliographic Databases

Help

Search results

Your search

kw.\*:("Tiazolidinediona derivado")

Filter

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Document Type [dt]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Publication Year[py]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Discipline (document) [di]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Language

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Author Country

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Results 1 to 25 of 1948

  • Page / 78

Export

Selection :

  • and

Thiazolidinediones in dermatologyBOYD, Alan S.International journal of dermatology. 2007, Vol 46, Num 6, pp 557-563, issn 0011-9059, 7 p.Article

ThiazolidinedionesYKI-JÄRVINEN, Hannele.The New England journal of medicine. 2004, Vol 351, Num 11, pp 1106-1118, issn 0028-4793, 13 p.Article

Sequence variation in PPARG may underlie differential response to troglitazoneWOLFORD, Johanna K; YEATTS, Kimberly A; DHANJAL, Sharanjeet K et al.Diabetes (New York, NY). 2005, Vol 54, Num 11, pp 3319-3325, issn 0012-1797, 7 p.Article

Troglitazone : the lesson that nobody learned?GALE, Edwin A. M.Diabetologia (Berlin). 2006, Vol 49, Num 1, pp 1-6, issn 0012-186X, 6 p.Article

Visfatin is an adipokine, but it is not regulated by thiazolidinedionesHAMMARSTEDT, Ann; PIHLAJAMÄKI, Jussi; SOPASAKIS, Victoria Rotter et al.The Journal of clinical endocrinology and metabolism. 2006, Vol 91, Num 3, pp 1181-1184, issn 0021-972X, 4 p.Article

MCC-555-induced NAG-1 expression is mediated in part by KLF4CEKANOVA, Maria; LEE, Seong-Ho; MCENTEE, Michael F et al.European journal of pharmacology. 2010, Vol 637, Num 1-3, pp 30-37, issn 0014-2999, 8 p.Article

Thiazolidinediones and fluid retentionKIRYLUK, K; ISOM, R.Kidney international. 2007, Vol 72, Num 6, pp 762-768, issn 0085-2538, 7 p.Article

Pleiotropic actions of PPARγ activators thiazolidinediones in cardiovascular diseasesTAKANO, Hiroyuki; HASEGAWA, Hiroshi; ZOU, Yunzeng et al.Current pharmaceutical design. 2004, Vol 10, Num 22, pp 2779-2786, issn 1381-6128, 8 p.Article

ROSIGLITAZONE WHAT WENT WRONGCOHEN, Deborah.BMJ (Overseas and retired doctors ed.). 2010, Vol 341, Num 7772, pp 530-534, issn 1759-2151, 5 p.Article

Ineffectiveness of rosiglitazone therapy in nelson's syndromeMUNIR, A; SONG, F; INCE, P et al.The Journal of clinical endocrinology and metabolism. 2007, Vol 92, Num 5, pp 1758-1763, issn 0021-972X, 6 p.Article

Physiological Responses to Acute Psychological Stress Are Reduced by the PPARγ Agonist RosiglitazoneRYAN, Karen K; GRAYSON, Bernadette E; JONES, Kenneth R et al.Endocrinology (Philadelphia). 2012, Vol 153, Num 3, pp 1279-1287, issn 0013-7227, 9 p.Article

Rosiglitazone, marketing, and medical scienceMOYNIHAN, Ray.BMJ. British medical journal (International ed.). 2010, Vol 340, Num 7750, pp 785-788, issn 0959-8146, 4 p.Article

Thiazolidinediones increase the wingless-type MMTV integration site family (WNT) inhibitor Dickkopf-1 in adipocytes: a link with osteogenesisGUSTAFSON, B; ELIASSON, B; SMITH, U et al.Diabetologia (Berlin). 2010, Vol 53, Num 3, pp 536-540, issn 0012-186X, 5 p.Article

Ontology-based knowledge management of troglitazone-induced hepatotoxicityHUG, Hubert; DANNECKER, Robert; SCHINDLER, Richard et al.Drug discovery today. 2004, Vol 9, Num 22, pp 948-954, issn 1359-6446, 7 p.Article

Effects of troglitazone in young first-degree Relatives of patients with type 2 diabetesLEVIN, Klaus; HOTHER-NIELSEN, Ole; HENRIKSEN, Jan Erik et al.Diabetes care. 2004, Vol 27, Num 1, pp 148-154, issn 0149-5992, 7 p.Article

Progress with thiazolidinediones in the management of type 2 diabetes mellitusMERIDEN, Terry.Clinical therapeutics. 2004, Vol 26, Num 2, pp 177-190, issn 0149-2918, 14 p.Article

Thiazolidinediones: metabolic actions in vitroFÜRNSINN, C; WALDHÄUSL, W.Diabetologia (Berlin). 2002, Vol 45, Num 9, pp 1211-1223, issn 0012-186X, 13 p.Article

Rosiglitazone induces decreases in bone mass and strength that are reminiscent of aged boneLAZARENKO, Oxana P; RZONCA, Sylwia O; HOGUE, William R et al.Endocrinology (Philadelphia). 2007, Vol 148, Num 6, pp 2669-2680, issn 0013-7227, 12 p.Article

Plasma concentrations of vascular endothelial growth factor are associated with peripheral oedema in patients treated with thiazolidinedioneEMOTO, M; FUKUDA, N; NAKAMORI, Y et al.Diabetologia (Berlin). 2006, Vol 49, Num 9, pp 2217-2218, issn 0012-186X, 2 p.Article

Avandamet° : Remboursement des dosages forts = Avandamet° : repayment of high doseLa Revue Prescrire. 2005, Vol 25, Num 263, issn 0247-7750, p. 502Article

Severe hypo-α-lipoproteinemia during treatment with rosiglitazoneSARKER, Anita; SEMPLE, Robert K; DINNEEN, Sean F et al.Diabetes care. 2004, Vol 27, Num 11, pp 2577-2580, issn 0149-5992, 4 p.Article

Rosiglitazone evaluated for cardiovascular outcomes - : An interim analysisHOME, Philip D; POCOCK, Stuart J; BECK-NIELSEN, Henning et al.The New England journal of medicine. 2007, Vol 357, Num 1, pp 28-38, issn 0028-4793, 11 p.Article

Necdin and E2F4 are modulated by rosiglitazone therapy in diabetic human adipose and muscle tissueGOLDFINE, Allison B; CRUNKHORN, Sarah; PATTI, Mary Elizabeth et al.Diabetes (New York, NY). 2006, Vol 55, Num 3, pp 640-650, issn 0012-1797, 11 p.Article

Adiponectin-dependent and -independent pathways in insulin-sensitizing and antidiabetic actions of thiazolidinedionesKUBOTA, Naoto; YAMAUCHI, Toshimasa; TOBE, Kazuyuki et al.Diabetes (New York, NY). 2006, Vol 55, issn 0012-1797, S32-S38, SUP2Conference Paper

Stay vigilant: a glitazone (pioglitazone) can hide a glitazar!HILLAIRE-BUYS, Dominique; FAILLIE, Jean-Luc; MONTASTRUC, Jean-Louis et al.European journal of clinical pharmacology. 2012, Vol 68, Num 12, pp 1681-1683, issn 0031-6970, 3 p.Article

  • Page / 78